Medicaid Medical Loss Ratio Fraud: Calling It Care Does Not Make It Care

Medicaid medical loss ratio fraud inflates a health plan’s reported spending on care to reduce money it must return or distort the costs used to set future payments. The change can happen in a provider payment, a shared-expense allocation or the report sent to the state. If you work in finance, you may know why a consulting bill became a medical expense, who approved the classification and what the plan actually bought. That is where we start.

What Is a Medicaid Capitation Payment?

A Medicaid capitation payment is a fixed periodic payment to a managed-care plan for each enrolled beneficiary. The state pays for coverage under the contract, rather than paying the plan separately for every appointment. The plan then pays providers through its own arrangements, which can include fees for services or further capitated payments.

That leaves an accounting question behind the state’s payment: how much reached patient care? Medical loss ratio reporting separates spending on care and qualifying quality improvements from administration and profit. The plan submits an annual report to the state, and the state submits a summary to the Centers for Medicare & Medicaid Services.

How Is the Medical Loss Ratio Calculated?

The medical loss ratio compares allowed medical spending and qualifying quality-improvement expenses with the plan’s adjusted premium revenue. The spending side is the numerator. The revenue side is the denominator. Calling an administrative expense medical raises the reported share spent on care without changing what the money purchased.

The federal managed-care rules make the classification consequential on both sides. State-directed payments to providers belong among incurred claims, while the corresponding payments from the state to the plan belong in premium revenue. Counting the outgoing payment while leaving out the incoming funding distorts the comparison.

Administrative Costs Behind a Provider Payment

Payments to outside vendors for claims processing, network development and utilization management are excluded from medical claims. So are payments to a provider for administrative services rather than covered care. Passing the money through a healthcare provider does not change the service purchased.

A management contract may serve several lines of business. Shared costs must be assigned to the contracts incurring them, and the Centers for Medicare & Medicaid Services requires plans to explain their allocation methods. The schedule shows how much was assigned to Medicaid and why.

The agency also requires the underlying medical and nonmedical spending data when a plan delegates work to a subcontractor. A single payment to the subcontractor can conceal the split that the plan still has to report.

Quality Improvement and Provider Incentives

The federal rule adopted in 2024 limits quality-improvement spending to expenses directly related to improving health care quality. Software infrastructure primarily supporting billing, enrollment, claims processing or financial analysis cannot be counted in that category.

Provider incentive payments must connect to clearly defined, measurable and documented clinical or quality standards. The Centers for Medicare & Medicaid Services found arrangements with no required performance improvement and contracts signed after the performance period.

Additional contract requirements start with the first rating period beginning at least one year after July 9, 2024: a defined performance period, signatures before it starts and payment terms tied to the measures. We compare the bonus agreement’s date and performance data with the payment.

How Are Overpayments Handled in Medicaid?

Medicaid managed-care plans must exclude provider overpayments from reported medical claims. For money a plan owes back because of its medical loss ratio, the state’s requirements and the plan’s contract determine the payback.

Federal rules require states to set capitation rates so plans can reasonably spend at least 85% of adjusted premium revenue on care and qualifying quality improvements. A state may impose a minimum at that level or higher and require plans falling below it to return money.

The federal reporting duty applies even where a state has not imposed that remittance requirement. The Centers for Medicare & Medicaid Services explains that inappropriate provider incentives can inflate both the reported ratio and the costs used to develop future capitation rates. The effect reaches beyond the current year’s payback.

States must consider past and projected medical loss ratios when developing rates. A recovered provider overpayment left in reported claims overstates medical spending.

WellCare’s Behavioral-Health Spending and the Money Kept Inside

WellCare agreed to a $137.5 million civil settlement in April 2012. The Justice Department alleged several schemes, including falsely inflating reported medical spending to avoid returning money to Medicaid and other programs. A former financial analyst’s qui tam complaint initiated the government’s investigation. The announcement said that analyst would receive approximately $20.75 million.

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

In the criminal case against former WellCare executives, the court’s opinion says the government proved at trial that the executives helped submit false Medicaid expense reports. Florida’s rule, enacted in 2002, required the relevant plans to spend at least 80% of the designated behavioral-health premium on the covered services and refund the shortfall. The contracts at issue applied that requirement to community mental health and targeted case management services.

The court described a subsidiary arrangement that moved money inside WellCare while preserving its profits. A company allocation slide showed the WellCare entities retaining 55% of the behavioral-health premium for administration, overhead and profit, against a permitted 20%. Moving the payment to another company in the same group supplied the appearance of medical spending.

The reporting process was remarkably simple. Florida’s Agency for Health Care Administration supplied a worksheet with the premium already entered. The plans filled in their expenses, and the remaining calculations produced the refund. The chief executive or president certified the expenses. The court described false and inflated entries in that expense line.

The money took a trip through a subsidiary. The state received a larger medical-expense number.

Gold Coast and Payments for Additional Services

Gold Coast Health Plan and three healthcare providers agreed to $70.7 million across separate civil settlements in August 2022. Gold Coast’s own payment was $17.2 million.

Gold Coast arranges Medi-Cal services in Ventura County. Under the California Department of Health Care Services contracts described in the Justice Department’s announcement, county organized health systems had to spend at least 85% of their adult-expansion funding on allowed medical expenses or return the difference. California then owed that money back to the federal government.

The United States and California alleged that payments for additional services between January 1, 2014, and May 31, 2015, failed that contract’s requirements. The allegations included predetermined amounts that did not reflect the services’ fair market value and payments for services providers already had to deliver.

This puts the provider agreement beside the plan’s expense classification. If a payment purchased work already included in the contract, the description on the later invoice cannot explain what additional care the government bought. The former controller and former director of member services brought the whistleblower case. Their roles put the accounting and the plan’s obligations in the same investigation.

Inland Empire and the Incentive That Arrived After the Work

In its September 2025 complaint, the United States alleged that Inland Empire Health Plan wrongfully retained at least $320 million in federal funding through sham incentives and an extra-contractual retroactive rate increase. The government’s case centers on spending that allegedly failed the plan’s California contract for the expansion population.

The complaint identifies January 1, 2014, through June 30, 2016, as the period subject to the surplus-return requirement. It alleges that IEHP used expansion money for other patient populations and administrative work, conserving funding it would otherwise have had to spend. It also alleges that the plan disguised payments for consultants and technology services by routing them through providers.

The complaint quotes an executive’s explanation of that route:

That alleged instruction connects the payment route directly to the desired reporting result. The consultant’s work stayed the same. A hospital in the middle made it look medical.

The incentive allegations are equally specific. The government alleged that IEHP set hospital-use targets after it already knew providers had met them, then notified providers near the end of the period it purported to reward. We find the premise hard to take seriously: an incentive announced after the behavior it supposedly encouraged.

The contract terms quoted in the complaint also tied allowed expenses to services delivered within the reporting period and required accurate spending certifications. The agreement, the service date, the incentive announcement and the report each answer a different part of the allegation.

What the Plan’s Accounting Records Can Show

A medical loss ratio fraud inquiry follows a cost from the work purchased to the report certified. We compare the state contract and amendments with provider agreements, invoices, payment records, allocation schedules and the spending report. The important questions are what service the payment bought, which population benefited, when the work occurred and who decided how to classify it.

A 1999 Harvard Kennedy School report, Controlling Fraud and Abuse in Medicaid: Innovations and Obstacles, found that state officials were confusing fraud against managed-care organizations with fraud by those organizations. Its description of plan misconduct still explains why the accounting trail matters:

The report identified sham management contracts and related-party transactions among the practices officials had encountered. WellCare’s subsidiary arrangement and the routing alleged in IEHP show why looking only at the final provider payment misses the decision inside the plan.

We work with controllers, cost accountants and reporting staff to connect those decisions to the state’s money. Our evaluation also identifies the Medicaid whistleblower lawyers whose experience fits the plan’s contracts and accounting.

When the Review Stops Before the Rate Decision

In its September 2026 review of CMS’s accuracy checks, the HHS Office of Inspector General found that limited checks identified potentially inaccurate state-submitted medical loss ratio data, but CMS did not follow up with the states.

The results also did not reach the agency’s staff reviewing capitation rates.

An accuracy check that stops before anyone resolves the discrepancy leaves the next payment decision exposed. That is why we follow both destinations of the reported expense: the money the plan must return and the costs used to set its next payments.

You Know What the Payment Bought

If you know why a plan reported overhead, duplicate services or a backdated incentive as medical spending, speak with our whistleblower experts about the classification and the people behind it. We build your strongest Medicaid whistleblower case around the contract, the accounting and the decisions that kept government money inside the plan. We bring in Medicaid managed-care whistleblower lawyers and remain your partners through the case.